PDL BioPharma, Inc. Financing Receivable, after Allowance for Credit Loss, Current
PDL BioPharma, Inc. had Financing Receivable, after Allowance for Credit Loss, Current of $52.60 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2021-03-29
- 2020-06-30: Financing Receivable, after Allowance for Credit Loss, Current $52.60M.
- 2020-03-31: Financing Receivable, after Allowance for Credit Loss, Current $52.58M.
- 2019-12-31: Financing Receivable, after Allowance for Credit Loss, Current $52.58M.
- 2019-09-30: Financing Receivable, after Allowance for Credit Loss, Current $63.32M.
| Period end | Financing Receivable, after Allowance for Credit Loss, Current | Financing Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2020-06-30 | $52.60M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $52.58M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $52.58M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $63.32M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $63.28M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $63.06M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $63.04M 8-K · filed 2020-06-29 | |
| 2018-09-30 | $60.28M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $58.06M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $55.84M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $53.61M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $57.55M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $62.36M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $103.62M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $111.18M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $131.12M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $95.36M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $84.61M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $58.40M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $67.25M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $64.80M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $63.44M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $57.60M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $55.29M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $6.60M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $1.20M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.21M 10-K · filed 2015-02-23 | $13.00K 10-K · filed 2014-03-03 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $40.00K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $44.68M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $7.50M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $13.18M 10-Q · filed 2012-11-05 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-01 |